| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.36 | 8e-17 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |